Dallah Healthcare Company SJSC 4004.SR · SAR

Health Care · Tadawul · 🇸🇦 Saudi Arabia

Compare

58.50

-0.34%

Close of 9 Nov 2026, in SAR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SAR, from our data supplier.

FY2025

Revenue

SAR 4.07bn

FY2016FY2025

Net income

SAR 538.0m

FY2016FY2025

Free cash flow

−SAR 79.4m

FY2016FY2025

Shareholders' equity

SAR 4.08bn

FY2016FY2025

Income statement

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Revenue	SAR 4.07bn	SAR 3.21bn	SAR 2.94bn	SAR 2.49bn	SAR 2.11bn	SAR 1.32bn	SAR 1.25bn	SAR 1.18bn	SAR 1.21bn	SAR 1.16bn
Gross profit	SAR 1.42bn	SAR 1.21bn	SAR 1.08bn	SAR 895.1m	SAR 760.4m	SAR 449.7m	SAR 447.8m	SAR 436.3m	SAR 559.1m	SAR 536.8m
Operating income	SAR 558.8m	SAR 567.1m	SAR 506.3m	SAR 422.4m	SAR 364.7m	SAR 125.2m	SAR 154.4m	SAR 146.2m	SAR 308.0m	SAR 239.1m
Net income	SAR 538.0m	SAR 471.2m	SAR 360.1m	SAR 274.5m	SAR 258.6m	SAR 97.1m	SAR 146.9m	SAR 141.8m	SAR 295.0m	SAR 225.8m
Diluted earnings per share	5.29	4.83	3.69	3.05	2.40	1.11	1.66	1.58	3.28	2.51

Balance sheet

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Total assets	SAR 9.14bn	SAR 6.61bn	SAR 6.24bn	SAR 4.92bn	SAR 4.65bn	SAR 3.99bn	SAR 2.92bn	SAR 2.70bn	SAR 2.53bn	SAR 2.25bn
Cash and short-term investments	SAR 210.6m	SAR 284.8m	SAR 235.3m	SAR 237.9m	SAR 208.1m	SAR 130.6m	SAR 88.3m	SAR 46.4m	SAR 118.6m	SAR 186.6m
Total liabilities	SAR 5.02bn	SAR 2.87bn	SAR 2.77bn	SAR 2.69bn	SAR 2.55bn	SAR 2.14bn	SAR 1.39bn	SAR 1.10bn	SAR 836.1m	SAR 738.4m
Debt	SAR 3.81bn	SAR 2.02bn	SAR 1.97bn	SAR 1.98bn	SAR 1.89bn	SAR 1.53bn	SAR 1.04bn	SAR 708.4m	SAR 563.8m	SAR 481.4m
Shareholders' equity	SAR 4.08bn	SAR 3.47bn	SAR 3.20bn	SAR 1.99bn	SAR 1.87bn	SAR 1.76bn	SAR 1.52bn	SAR 1.60bn	SAR 1.69bn	SAR 1.51bn
Shares outstanding	102m	97m	98m	90m	108m	88m	88m	90m	90m	90m

Cash flow

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Cash from operations	SAR 385.9m	SAR 678.3m	SAR 625.8m	SAR 442.1m	SAR 361.5m	SAR 183.3m	SAR 307.1m	SAR 204.7m	SAR 353.1m	SAR 341.6m
Capital spending	−SAR 465.3m	−SAR 365.3m	−SAR 296.7m	−SAR 175.0m	−SAR 115.7m	−SAR 129.7m	−SAR 201.1m	−SAR 256.1m	−SAR 431.4m	−SAR 316.4m
Free cash flow	−SAR 79.4m	SAR 313.0m	SAR 329.1m	SAR 267.1m	SAR 245.9m	SAR 53.6m	SAR 106.1m	−SAR 51.4m	−SAR 78.4m	SAR 25.2m
Dividends paid	−SAR 202.4m	−SAR 201.2m	−SAR 146.5m	−SAR 180.0m	−SAR 162.5m	−SAR 99.9m	−SAR 123.9m	−SAR 147.5m	−SAR 118.0m	−SAR 88.5m

Latest quarters

By quarter end

	Jun 2026	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024
Revenue	SAR 1.11bn	SAR 1.01bn	SAR 1.11bn	SAR 1.06bn	SAR 1.06bn	SAR 832.8m	SAR 808.8m	SAR 847.7m
Gross profit	SAR 387.4m	SAR 334.1m	SAR 371.2m	SAR 380.6m	SAR 375.9m	SAR 297.6m	SAR 292.8m	SAR 323.0m
Operating income	SAR 165.8m	—	SAR 77.4m	SAR 157.6m	SAR 155.0m	SAR 177.9m	SAR 115.4m	SAR 161.4m
Net income	SAR 100.0m	SAR 84.5m	SAR 117.0m	SAR 141.9m	SAR 124.3m	SAR 155.6m	SAR 113.9m	SAR 126.2m
Diluted earnings per share	0.99	0.84	1.15	1.39	1.22	1.53	1.17	1.29
Cash from operations	−SAR 2.0m	SAR 102.0m	SAR 136.0m	SAR 76.0m	−SAR 36.0m	SAR 248.0m	SAR 168.0m	SAR 245.0m
Capital spending	−SAR 120.0m	−SAR 148.0m	−SAR 133.0m	−SAR 80.0m	−SAR 87.0m	−SAR 165.0m	−SAR 94.0m	−SAR 152.0m
Free cash flow	−SAR 122.0m	−SAR 46.0m	SAR 3.0m	−SAR 4.0m	−SAR 123.0m	SAR 83.0m	SAR 74.0m	SAR 93.0m
Total assets	SAR 9.57bn	SAR 9.31bn	SAR 9.14bn	SAR 8.94bn	SAR 8.76bn	SAR 8.54bn	SAR 6.61bn	SAR 6.59bn
Cash and short-term investments	—	—	SAR 210.6m	SAR 153.7m	SAR 118.8m	SAR 175.1m	SAR 284.8m	SAR 208.2m
Debt	SAR 2.99bn	SAR 2.98bn	SAR 3.81bn	SAR 3.23bn	SAR 3.15bn	SAR 2.94bn	SAR 1.93bn	SAR 1.95bn
Shareholders' equity	SAR 4.13bn	SAR 4.10bn	SAR 4.08bn	SAR 4.23bn	SAR 4.13bn	SAR 4.06bn	SAR 3.47bn	SAR 3.41bn

Financial ratios

Data as of 3 Oct 2026

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Gross margin	34.9%	37.6%	36.7%	36.0%	36.1%	34.1%
Operating margin	13.7%	17.7%	17.2%	17.0%	17.3%	9.5%
Net margin	13.2%	14.7%	12.2%	11.0%	12.3%	7.4%
Return on equity	13.2%	13.6%	11.2%	13.8%	13.9%	5.5%
Return on assets	5.9%	7.1%	5.8%	5.6%	5.6%	2.4%
Free cash flow yield	11.1%	14.2%	12.5%	9.1%	5.9%	4.7%
Revenue growth	26.9%	8.9%	18.3%	18.2%	59.7%	5.3%
Earnings growth	14.2%	30.8%	31.2%	6.1%	166.3%	-33.9%
Current ratio	1.24x	1.15x	1.16x	1.47x	1.27x	1.35x
Debt to equity	0.93x	0.56x	0.60x	0.98x	1.01x	0.87x
Equity ratio	44.7%	52.4%	51.3%	40.4%	40.2%	44.1%
Interest coverage	3.71x	5.32x	4.86x	5.99x	8.72x	4.93x
Buybacks as a share of market value	-4.4%	0.2%	-8.5%	16.4%	-22.6%	0.8%

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	17.8%	25.3%	15.2%
Operating income	9.8%	34.9%	12.6%
Net income	25.2%	40.8%	12.5%

Average margins

Over each period

	1 year	3 years	5 years	10 years
Gross margin	36.1%	36.2%	36.0%	37.4%
Operating margin	15.5%	16.2%	15.8%	16.3%
Net margin	13.9%	12.9%	12.4%	13.6%

Valuation history

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Price to earnings	19.8	25.9	38.8	40.4	26.0	36.3	19.6	19.5	16.8	20.6
Price to sales	2.6	3.8	4.8	4.5	3.2	2.7	2.3	2.3	4.1	4.0

Dividends and splits

Per share, in the currency the company pays

Paid for 13 years. Last went ex-dividend on 10 Aug 2026.

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Paid in the year	1.25	1.667	1.25	1.667	1.667	1.458	0.903	0.347

6-for-5 split · 14 Sept 2020
1.271-for-1 split · 27 Feb 2019
5-for-4 split · 13 Oct 2015

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

Dallah Healthcare Company SJSC 4004.SR · SAR

Search any instrument

At a glance

Income statement

Balance sheet

Cash flow

Latest quarters

Financial ratios

Growth per year

Average margins

Valuation history

Dividends and splits

Sources and methodology